For cost-effective cures, the drug pricing policy challenge is not simply to lower prices, but also to spread the drug costs among payers.
Patricia J. Zettler, JD
Advertisement
Articles by Patricia J. Zettler, JD
Advertisement
Latest Updated Articles
- The Challenge of Paying for Cost-Effective Cures
January 17th 2017
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
ICER Draft Flags High Cost of New Hypertension Drug Class
3
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
4
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
5